Literature DB >> 1165475

Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.

R D Schreiber, R G Medicus, O Gïtze, H J Müller-Eberhard.   

Abstract

Two complex enzymes were assembled that both converted C3 to C3b, one consisting of activated properdin (P), native C3, proactivator (PA) and proactivator convertase (PAase), and the other of nephritic factor (NF) and the same three cofactors. By maintaining a critical concentration of PAase, the P-C3 convertase and the NF-C3 convertase were shown to function efficiently without formation of the C3b-feedback enzyme. The former two enzymes are distinct from the C3b-dependent C3 convertase in that they utilize native C3 instead of C3b and PA in an apparently uncleaved form. The P- and NF-C3 convertase express maximal activity within approximately 10 min at 37 degrees C and decay with a half-life of 35 min at 37 degrees C, which is in contradistinction to the reported lability of the C3b-feedback enzyme. P- and NF-C3 convertases are inhibited by their product C3b, which may constitute a heretofore unknown control of the alternative pathway. A direct physical interaction of P with native C3 and C3b was demonstrated by agglutination of C3b-bearing erythrocytes and by agglutination inhibition. Bound C3b thus constitutes the only known receptor of P and may fulfill an important localizing function for P and the P-C3 convertase in vivo. Although P and NF form functionally similar enzymes, they act independently of each other and are apparently immunochemically unrelated proteins.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1165475      PMCID: PMC2189914          DOI: 10.1084/jem.142.3.760

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis.

Authors:  D G Williams; P J Lachmann; J A Charlesworth; D K Peters
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

3.  Glomerular and dermal depostion of properdin in systemic lupus erythematosus.

Authors:  N Rothfield; H A Ross; J O Minta; I H Lepow
Journal:  N Engl J Med       Date:  1972-10-05       Impact factor: 91.245

4.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

5.  Studies of serum complement in the hypocomplementaemic nephritides.

Authors:  D G Williams; D K Peters; J Fallows; A Petrie; O Kourilsky; L Morel-Maroger; J S Cameron
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

6.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

7.  A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement.

Authors:  E H Vallota; O Götze; H L Spiegelberg; J Forristal; C D West; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

8.  Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.

Authors:  A N Theofilopoulos; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

9.  Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

10.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  43 in total

1.  Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.

Authors:  Viviana P Ferreira; Claudio Cortes; Michael K Pangburn
Journal:  Immunobiology       Date:  2010-02-12       Impact factor: 3.144

2.  Heterogeneity of nephritic factor and its identification as an immunoglobulin.

Authors:  A E Davis; J B Ziegler; E W Gelfand; F S Rosen; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

3.  Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

4.  Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

Authors:  R D Schreiber; M K Pangburn; P H Lesavre; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

5.  Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

6.  Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.

Authors:  D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

Review 8.  Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.

Authors:  Y Levy; J George; E Yona; Y Shoenfeld
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

9.  The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor".

Authors:  R E Jordon; K G Heine; G Tappeiner; L L Bushkell; T T Provost
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

10.  Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Authors:  J T Mayes; R D Schreiber; N R Cooper
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.